About Chemclin
Chemclin is a company based in Beijing (China) founded in 2007 was acquired by Actis in June 2013. Chemclin has raised $312.54 million across 3 funding rounds from investors including CICC, Actis and Orbimed.
- Headquarter Beijing, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$58.86 M (USD)-2.35as on Dec 31, 2024
-
Net Profit
$17.41 M (USD)-13.77as on Dec 31, 2024
-
EBITDA
$22.7 M (USD)-10.04as on Dec 31, 2024
-
Total Equity Funding
$312.54 M (USD)
in 3 rounds
-
Latest Funding Round
$292.04 M (USD), Series C
Aug 13, 2018
-
Investors
CICC
& 8 more
-
Employee Count
Not available
-
Acquired by
Actis
(Jun 01, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chemclin
Chemclin has successfully raised a total of $312.54M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $292.04 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Chemclin
Chemclin has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include CICC, Actis and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity & venture capital firm
|
Locked | Locked | Locked | |
|
Corporate-backed venture capital firm focused on retail tech, mobile tech, and multiple sectors
|
Locked | Locked | Locked | |
|
VC firm that does investment in early stage companies in the US & China
|
Locked | Locked | Locked |
Investor details for Chemclin
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chemclin
Investment portfolio details for Chemclin
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chemclin
Detailed financials for Chemclin
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chemclin Comparisons
Peer comparison for Chemclin
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chemclin
Detailed competitors of Chemclin
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chemclin
Complete news archive for Chemclin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chemclin
Chemclin was founded in 2007.
Chemclin is headquartered in Beijing, China.
Chemclin is a funded company, having raised a total of $312.54M across 3 funding rounds to date.
Annual revenue of Chemclin is $58.86M as on Dec 31, 2024.
Chemclin, founded in 2007 as a subsidiary of China Diagnostics Medical Corporation, is based in Beijing, China. Diagnostic reagents and instruments for in vitro applications are developed, manufactured, and distributed by the company. Coverage includes chemiluminescence immunoassays, radioimmunoassay kits, and clinical chemistry assays. Systems and reagents address infectious diseases, tumor markers, liver fibrosis, diabetes, thyroid function, and fertility testing.
Chemclin has 9 investors. Key investors include CICC, Actis, Orbimed, WI Harper Group, and Free Trade Zone Fund.